Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Primary biliary cholangitis triggered by DAAs-induced HCV clearance: a biological proof of concept.

Literature DB >> 29854373

Primary biliary cholangitis triggered by DAAs-induced HCV clearance: a biological proof of concept.

Maria Rendina¹, Nicola Maurizio Castellaneta¹, Giuseppe Losurdo¹, Antonino Castellaneta¹, Annamaria Cazzolla¹, Claudia Chialà¹, Francesca D'Errico¹, Alfredo Di Leo².

Abstract

Entities: Disease

Keywords: chronic hepatitis C; direct antiviral acting agents; immunomodulatory effect; interferon; primary biliary cholangitis

Year: 2018 PMID： 29854373 PMCID： PMC5956644 DOI： 10.1177/2040622318755651

Source DB: PubMed Journal: Ther Adv Chronic Dis ISSN： 2040-6223 Impact factor: 5.091

× No keyword cloud information.

11 in total

Review 1. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update.

Authors: H Okada; C Kuhn; H Feillet; J-F Bach
Journal: Clin Exp Immunol Date: 2010-04 Impact factor: 4.330

2. Antimitochondrial antibody -M2 positive autoimmune hepatitis during standard of care for chronic hepatitis C.

Authors: Fabio Salvatore Macaluso; Nicola Alessi; Daniela Cabibi
Journal: Hepatol Res Date: 2012-04 Impact factor: 4.288

3. EASL Recommendations on Treatment of Hepatitis C 2016.

Authors:
Journal: J Hepatol Date: 2016-09-22 Impact factor: 25.083

4. Normal alkaline phosphatase in primary biliary cirrhosis.

Authors: D Leslie
Journal: Postgrad Med J Date: 1978-04 Impact factor: 2.401

5. The value of antinuclear antibodies in primary biliary cirrhosis.

Authors: Lixia Gao; Xinping Tian; Bin Liu; Fengchun Zhang
Journal: Clin Exp Med Date: 2008-04-03 Impact factor: 3.984

Review 6. Primary biliary cirrhosis induced by interferon-alpha therapy for hepatitis C virus infection.

Authors: E D'Amico; M Paroli; V Fratelli; C Palazzi; V Barnaba; F Callea; G Consoli
Journal: Dig Dis Sci Date: 1995-10 Impact factor: 3.199

7. Type1 and type2 memory T cells imbalance shown by expression of intrahepatic chemokine receptors relates to pathogenesis of primary biliary cirrhosis.

Authors: Kenichi Harada; Koichi Tsuneyama; Mitsue Yasoshima; Yoshiko Kanemori; Hajime Ohta; Shinji Masuda; Nobuyuki Onai; Kouji Matsushima; Yasuni Nakanuma
Journal: Hepatol Res Date: 2002-11 Impact factor: 4.288

8. Changes in the Th1/Th2 ratio during a 24-week course of an interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C.

Authors: Tomoko Fujimoto; Masahiko Tomimatsu; Daijiro Iga; Hitoshi Endo; Kuniaki Otsuka
Journal: J Gastroenterol Hepatol Date: 2008-02-03 Impact factor: 4.029

9. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.

Authors: Christophe Corpechot; Ludovico Abenavoli; Nabila Rabahi; Yves Chrétien; Tony Andréani; Catherine Johanet; Olivier Chazouillères; Raoul Poupon
Journal: Hepatology Date: 2008-09 Impact factor: 17.425

10. Primary Biliary Cirrhosis with a normal Alkaline Phosphatase: a case report.

Authors: Joshua M Brostoff; Sukaina Rashid; Daniel McCrea
Journal: Cases J Date: 2008-07-14

3 in total

1. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors: Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal: Infection Date: 2018-09-25 Impact factor: 3.553

2. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

3. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

3 in total